April 9th, 2015
Manesh R. Patel discusses his research group’s retrospective analysis of data on digoxin use among patients with atrial fibrillation in the ROCKET AF trial.
December 8th, 2010
The ROCKET-AF trial, which was recently presented at AHA, showed that the experimental factor Xa inhibitor rivaroxaban was as effective as warfarin in preventing stroke in 14,264 AF patients and did not increase their risk of bleeding. CardioExchange welcomes one of the trial’s investigators, Manesh Patel of the Duke Clinical Research Institute, to answer our […]